Oxygen uptake-velocity regression equations were developed for floor and level treadmill walking by having two groups of men, aged 19-29 years (n = 20) and 55-66 years (n = 22), walk at four self-selected paces, from "rather slowly" to "as fast as possible". A two-variable quadratic model relating VO2 (ml X kg-1 X min-1) to velocity (m X s-1) was adopted for prediction purposes. However, age and fatness significantly (P less than 0.05) interacted with treadmill walking speed, while age alone significantly interacted with floor speed. In addition, a significant difference was found between the energy cost of floor and treadmill walking. For example at the normal walking speed of 1.33 m X s-1, the energy cost for the treadmill (age 55-66 years) was 10.58 ml X kg-1 X min-1 and for the floor, 11.04 ml X kg-1 X min-1 (P less than 0.05). Four quadratic equations are therefore presented, one each for floor and treadmill in each of the two age-groups. The percent variance explained was between 87 and 95% for each of these equations.

To describe the association between self-selected speeds of walking, and age, maximal aerobic power, and body size, 84 men aged 19 to 66 years were asked to walk at four self-selected paces, from rather slowly to as fast as possible. Speed of walking was measured over a 240-m indoor course. Maximal oxygen uptake was determined on a treadmill. The speed of walking was significantly slower in the oldest (55 to 66 years) compared with the youngest group (19 to 29 years) at the normal fast, and as fast as possible speeds. However, when age, weight, height, and fatness were held constant in a multiple regression model, VO2 max was significantly related to speed of walking at the three fastest walking paces. Age was not significantly related to speed of walking at any pace. Thus, this study indicated that the speed of self-selected walking paces was associated with maximal aerobic power independent of age.

Chronic HCV is associated with a higher risk of mortality.SVR from DAAs was associated with a significant reduction in the risk of all-cause, liver-and drug-related mortality.Older age and cirrhosis were associated with higher risk of liverrelated mortality.Younger age, injection drug use, and problematic alcohol use were associated with higher risk of drug-related mortality.

BackgroundFactors associated with HCV incidence among young Aboriginal people in Canada are still not well understood. We sought to estimate time to HCV infection and the relative hazard of risk factors associated HCV infection among young Aboriginal people who use injection drugs in two Canadian cities.MethodsThe Cedar Project is a prospective cohort study involving young Aboriginal people in Vancouver and Prince George, British Columbia, who use illicit drugs. Participants’ venous blood samples were drawn and tested for HCV antibodies. Analysis was restricted to participants who use used injection drugs at enrolment or any of follow up visit. Cox proportional hazards regression was used to identify independent predictors of time to HCV seroconversion.ResultsIn total, 45 out of 148 participants seroconverted over the study period. Incidence of HCV infection was 26.3 per 100 person-years (95% Confidence Interval [CI]: 16.3, 46.1) among participants who reported using injection drugs for two years or less, 14.4 per 100 person-years (95% CI: 7.7, 28.9) among participants who had been using injection drugs for between two and five years, and 5.1 per 100 person-years (95% CI: 2.6,10.9) among participants who had been using injection drugs for over five years. Independent associations with HCV seroconversion were involvement in sex work in the last six months (Adjusted Hazard Ratio (AHR): 1.59; 95% CI: 1.05, 2.42) compared to no involvement, having been using injection drugs for less than two years (AHR: 4.14; 95% CI: 1.91, 8.94) and for between two and five years (AHR: 2.12; 95%CI: 0.94, 4.77) compared to over five years, daily cocaine injection in the last six months (AHR: 2.47; 95% CI: 1.51, 4.05) compared to less than daily, and sharing intravenous needles in the last six months (AHR: 2.56; 95% CI: 1.47, 4.49) compared to not sharing.ConclusionsThis study contributes to the limited body of research addressing HCV infection among Aboriginal people in Canada. The HCV incidence rate among Cedar Project participants who were new initiates of injection drug use underscores an urgent need for HCV and injection prevention and safety strategies aimed at supporting young people surviving injection drug use and sex work in both cities. Young people must be afforded the opportunity to provide leadership and input in the development of prevention programming.